Elite Pharma Launches Acetaminophen and Codeine Phosphate Tablets
Elite Pharma launches acetaminophen and codeine phosphate tablets for management of mild to moderate pain
Overview
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company developing niche generic products, announced that the company has launched Elite's generic version of Tylenol with Codeine (acetaminophen and codeine phosphate) 300mg/15mg, 300mg/30mg, and 300mg/60mg tablets.
Indication
Acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate.
This product is marketed and sold under the Elite Laboratories, Inc. label.
Estimated Sale in US
According to IQVIA, the total US sales of acetaminophen and codeine, 300mg/15mg, 300mg/30mg, and 300mg/60mg, was approximately $47 million for the 12 months ended May 2024.
About the Company: Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops, manufactures, and distributes niche generic products.
Elite's product lines consist of immediate-release and controlled-release, solid oral dose products, which are marketed under the Elite Laboratories label, as well as pursuant to licenses granted to third-party pharmaceutical marketing and distribution organizations.